Cargando…
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179126/ https://www.ncbi.nlm.nih.gov/pubmed/35690075 http://dx.doi.org/10.1016/S1473-3099(22)00365-6 |
| _version_ | 1784723200174718976 |
|---|---|
| author | Yamasoba, Daichi Kosugi, Yusuke Kimura, Izumi Fujita, Shigeru Uriu, Keiya Ito, Jumpei Sato, Kei |
| author_facet | Yamasoba, Daichi Kosugi, Yusuke Kimura, Izumi Fujita, Shigeru Uriu, Keiya Ito, Jumpei Sato, Kei |
| author_sort | Yamasoba, Daichi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9179126 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91791262022-06-09 Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies Yamasoba, Daichi Kosugi, Yusuke Kimura, Izumi Fujita, Shigeru Uriu, Keiya Ito, Jumpei Sato, Kei Lancet Infect Dis Correspondence Elsevier Ltd. 2022-07 2022-06-09 /pmc/articles/PMC9179126/ /pubmed/35690075 http://dx.doi.org/10.1016/S1473-3099(22)00365-6 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Yamasoba, Daichi Kosugi, Yusuke Kimura, Izumi Fujita, Shigeru Uriu, Keiya Ito, Jumpei Sato, Kei Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title_full | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title_fullStr | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title_full_unstemmed | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title_short | Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies |
| title_sort | neutralisation sensitivity of sars-cov-2 omicron subvariants to therapeutic monoclonal antibodies |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179126/ https://www.ncbi.nlm.nih.gov/pubmed/35690075 http://dx.doi.org/10.1016/S1473-3099(22)00365-6 |
| work_keys_str_mv | AT yamasobadaichi neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT kosugiyusuke neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT kimuraizumi neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT fujitashigeru neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT uriukeiya neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT itojumpei neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies AT satokei neutralisationsensitivityofsarscov2omicronsubvariantstotherapeuticmonoclonalantibodies |